Lv710
4740 积分 2024-07-23 加入
Genetics of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in the Indian Ethnicity: An Update
16小时前
待确认
Comorbid Cardiovascular-Liver Disease Disparities: Current Understanding and Future Directions
17小时前
已完结
Heart–liver co-management in MASLD: expert perspectives and recommendations from a multidisciplinary cardiometabolic framework
23小时前
已完结
International expert panel review for the use of resmetirom and semaglutide in the management of MASH-related fibrosis: clinical practice update
1天前
已完结
Novel Combination of Metronomic Cyclophosphamide and Darolutamide Induces Sustained Clinical Response in Heavily Treated Prostate Cancer with Prostate-Specific Membrane Antigen-Negative Liver Metastases and Rapid Disease Progression
10天前
已完结
A phase I/II trial of concurrent chemo-hormonal enzalutamide and cabazitaxel in patients with metastatic castration-resistant prostate cancer
10天前
已完结
Olaparib combined with abiraterone in HRR-mutated metastatic hormone-sensitive prostate cancer: a single-arm phase II trial
10天前
已完结
Testosterone breakthrough and outcomes during intensified therapy in metastatic hormone‐sensitive prostate cancer: the ARASENS and LATITUDE trials
13天前
已完结
Excellent Response to Combined 223Ra-dichloride and Enzalutamide After Failure of 177Lu-PSMA Radioligand Therapy
13天前
已完结
[ 177 Lu]Lu‐PSMA‐617 Plus Short‐Course Priming With Enzalutamide in Metastatic Castration‐Resistant Prostate Cancer: A Single‐Arm Phase 2 Trial (Lu‐PRIME)
13天前
已完结
皖公网安备34019202002308
